Restructuring costs Bayer €1.203bn

German pharmaceutical giant Bayer has posted a 2003 operating loss of €1.203bn - worse than analyst expectations - but the group said it is aiming for an earnings growth for 2004.

Sales dropped 3.6% on last year to €28.567bn, as Bayer restructures shedding most of its chemicals businesses.